Welcome to our dedicated page for ChromaDex Corporation news (Ticker: $CDXC), a resource for investors and traders seeking the latest updates and insights on ChromaDex Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ChromaDex Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ChromaDex Corporation's position in the market.
ChromaDex (NASDAQ:CDXC) reported first quarter 2024 financial results with total net sales of $22.2 million, gross margin of 60.7%, a net loss of $0.5 million, and positive Adjusted EBITDA of $0.7 million. The company reiterated a full-year outlook with net sales growth of at least 16%. Tru Niagen® contributed $17.4 million to total net sales, and ChromaDex expanded distribution through partnerships with The Vitamin Shoppe and Sprouts Farmers Market. Operating expenses decreased, net loss improved, and Adjusted EBITDA turned positive. The company aims for revenue growth, gross margin improvement, and increased investments in research and development, marketing, and product launches.
ChromaDex announces an ingredient partnership with Solgar, a Nestlé Health Science brand, introducing Solgar Cellular Energy supplement featuring ChromaDex's NIAGEN NR. The collaboration aims to boost NAD+ levels for cellular health, highlighting NIAGEN as the gold standard in NAD+ supplements. NIAGEN NR, supported by extensive research, increases NAD+ by over 50% in two weeks. Solgar Cellular Energy also includes B vitamins and vitamin C for comprehensive health benefits.